ClinicalTrials.gg
Not yet recruitingNCT06323746Updated May 30, 2024

Exploring Heart Rate Variability, EEG Pattern, and Corticomuscular Coherence After Cervical Sagittal Alignment Restoration

An interventional study of Denneroll cervical traction orthodontic in Cervical Lordosis, sponsored by University of Sharjah. Not yet recruiting at 1 site in United Arab Emirates. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-30.

Sponsored by University of Sharjah · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The goal of this Randomized clinical trial is to learn about how fixing neck curvature and head posture right away affects heart rate, brainwaves, and muscle coordination in college athletes. The main question it aims to answer:

  • Whether forward head posture (FHP) may play a crucial role in affecting heart rate variability, brainwaves, and muscle coordination.
Read the detailed description

Background: Restoring normal cervical spine alignment has emerged as one of the most important clinical outcomes in healthcare. However, the question of whether cervical biomechanical dysfunction manifesting as forward head posture (FHP) may play a crucial role in affecting heart rate variability, as an indicator of the autonomic nervous system, electroencephalography (EEG) pattern, as indictor for brain waves, and corticomuscular coherence, as an indicator of the functional connection between the cortex and muscles during continuous muscle contractions among collegiate athletes has not been answered yet.

Objective: To investigate the immediate and long-term effects of cervical lordosis restoration and forward head correction using the Denneroll™ on heart rate variability, EEG pattern, and corticomuscular coherence among collegiate athletes.

Methods: Eighty asymptomatic subjects with a definite hypolordotic cervical spine and FHP will be randomly assigned to an experimental group or a control group. The experimental group will receive the Denneroll™ cervical traction while the control group will be considered as a wait list to start the intervention after completion of the experimental group. Interventions will be applied 3 times per week for a period of 10 weeks. Changes in heart rate variability, EEG pattern and corticomuscular coherence will be assessed at three-time intervals: at baseline, after 10 weeks of intervention, and at 6-months follow up with no further interventions.

02

Conditions studied

  • Cervical Lordosis

Browse trials for

Keywords

  • Cervical Lordosis
  • Athlete
  • Electroencephalography
  • Heart Rate
03

In context

Lordosis

30 studies on the registry are indexed under Lordosis; 5 are open to participants now.

This study's planned enrollment of 80 is above the median of 50 across 15 interventional studies indexed under Lordosis.

Browse Lordosis studies →

Lead sponsor

University of Sharjah is the lead sponsor of 42 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Anterior head translation (AHT) >15 mm
  • Absolute rotatory angle C2 to C7 is \<25°
  • Athletic student

Exclusion criteria

Exclusion Criteria:

  • Inflammatory joint disease or other systemic pathologies
  • Prior history of overt injury and surgery relating to the musculoskeletal system, or disorder related to the spine and extremities
  • Musculoskeletal pain in the previous three months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Denneroll Group

    The participants will be instructed to lie flat on their back on the ground with their legs extended and arms by their sides and gently folded across their stomach. The subject will place the Denneroll on the ground and the examiner positions the apex of the Denneroll. The apex of the Denneroll orthotic will be placed in one of three regions based on lateral cervical radiographic displacements.

    Device: Denneroll cervical traction orthodontic

  • Other
    Wait List

    This group will receive the same posture correction program after all data will be collected.

    Device: Denneroll cervical traction orthodontic

Interventions

  • DeviceDenneroll cervical traction orthodontic

    The duration of each session will start at approximately three minutes and increase by one minute per session until reaching the goal of 20 minutes per session. The intervention will be repeated three times per week for 10 weeks in the supervised setting.

06

What researchers measure

Primary outcomes

  1. Cervical Sagittal Alignment Radiographs

    The change of cervical lordosis from the absolute rotatory angle C2-7.

    Time frame: Baseline (pre-treatment), week 10 (upon completion) and after 6 months

  2. Cervical Sagittal Alignment Radiographs

    The amount of the change in the anterior head translation from the horizontal offset of the posterior superior body corner of C2 relative to the vertical line.

    Time frame: Baseline (pre-treatment), week 10 (upon completion) and after 6 months

Secondary outcomes

  1. Heart rate Variability (HRV) physiological parameter

    The change in Heart rate through Electrocardiographic recordings (ECG) will be monitored using a Nexus-10 physiologic monitoring system. Recordings will be made simultaneously through three separate channels. The ground electrode will be placed below the left clavicle, the cathode (-) below the right clavicle and the anode (+) will be placed on the third rib, in line with the ground. HRV time parameter will be calculated from respiratory rate (RR) intervals (Standard deviation of the normal to normal intervals (SDNN), Root-mean-square of the successive normal sinus RR interval difference (RMSSD) and the percentage of absolute differences between successive normal RR intervals that exceed 50 ms (pNN50)). HRV frequency domain variable will include total power, high frequency (HF) and low frequency (LF) power (measured in ms2) and LF:HF ratio were derived from spectral analysis of successive R-R intervals.

    Time frame: Baseline (pre-treatment), week 10 (upon completion) and after 6 months

  2. Corticomuscular Coherence

    The change in the ratio between Muscle activity through Electromyography (EMG) and brain waves through Electroencephalograph (EEG)

    Time frame: Baseline (pre-treatment), week 10 (upon completion) and after 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — No plan to make individual participant data (IPD) available to other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06323746
Lead sponsor
University of Sharjah
Responsible party
Ibrahim Moustafa (Professor and Chairman of Physiotherapy, University of Sharjah) — Principal investigator
First posted
Mar 21, 2024
Start date
May 2024 (estimated)
Primary completion
May 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 30, 2024

Study contacts

Shima Zadeh
Contact
Szadeh@sharjah.ac.ae
+971503077039
Ibrahim Mostafa Abuamr
Contact
iabuamr@sharjah.ac.ae

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion